Hiroaki Tanaka

Hiroaki Tanaka, PhD MBA, is a highly experienced professional who has held various executive and leadership roles in the biotech and pharmaceutical industry. Hiroaki is currently the Chief Executive Officer at EVbiome and a Member of The Supervisory Board at AEVA biotech. With a background in personalized medicine, Hiroaki has been instrumental in implementing personalized medicine initiatives in various organizations such as Debiopharm International SA and Merck Serono. Hiroaki also has experience in bioinformatics and commercial strategic projects. Hiroaki holds a PhD in Fundamental Pharmacology from Paris-Sud University, an Executive MBA from INSEAD, and an Engineer's degree from École Polytechnique.